MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
1.440
-0.070 (-4.64%)
Mar 31, 2025, 2:17 PM EDT - Market open
MDxHealth Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 90.05 | 70.19 | 37.05 | 22.24 | 18.46 | Upgrade
|
| Revenue Growth (YoY) | 28.29% | 89.43% | 66.62% | 20.47% | 56.64% | Upgrade
|
| Cost of Revenue | 34.91 | 26.26 | 17.84 | 11.68 | 10.42 | Upgrade
|
| Gross Profit | 55.14 | 43.93 | 19.22 | 10.56 | 8.04 | Upgrade
|
| Selling, General & Admin | 63.78 | 59.93 | 45.31 | 31.37 | 30.74 | Upgrade
|
| Research & Development | 10.55 | 6.38 | 5.45 | 5.59 | 4.27 | Upgrade
|
| Other Operating Expenses | 0.62 | -0.13 | 0.07 | -0.12 | -0.12 | Upgrade
|
| Operating Expenses | 79.86 | 70.67 | 54.01 | 38.45 | 34.89 | Upgrade
|
| Operating Income | -24.72 | -26.74 | -34.79 | -27.88 | -26.85 | Upgrade
|
| Interest Expense | -6.55 | -5.58 | -2.64 | -1.88 | -1.35 | Upgrade
|
| Interest & Investment Income | - | 1.09 | 0.13 | 0.01 | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | -6.41 | -2.12 | 0.01 | -0.1 | -0.19 | Upgrade
|
| EBT Excluding Unusual Items | -37.69 | -33.36 | -37.29 | -29.85 | -28.39 | Upgrade
|
| Merger & Restructuring Charges | - | - | -3.7 | - | - | Upgrade
|
| Asset Writedown | - | - | -0.04 | - | -0.27 | Upgrade
|
| Other Unusual Items | - | -9.74 | -3.01 | 0.85 | - | Upgrade
|
| Pretax Income | -37.69 | -43.1 | -44.04 | -29 | -28.66 | Upgrade
|
| Income Tax Expense | 0.38 | 0 | - | - | - | Upgrade
|
| Net Income | -38.07 | -43.1 | -44.04 | -29 | -28.66 | Upgrade
|
| Net Income to Common | -38.07 | -43.1 | -44.04 | -29 | -28.66 | Upgrade
|
| Shares Outstanding (Basic) | 33 | 26 | 16 | 12 | 8 | Upgrade
|
| Shares Outstanding (Diluted) | 33 | 26 | 16 | 12 | 8 | Upgrade
|
| Shares Change (YoY) | 26.66% | 63.31% | 30.12% | 46.56% | 32.95% | Upgrade
|
| EPS (Basic) | -1.16 | -1.66 | -2.78 | -2.38 | -3.44 | Upgrade
|
| EPS (Diluted) | -1.16 | -1.66 | -2.78 | -2.38 | -3.44 | Upgrade
|
| Free Cash Flow | -19.72 | -24.24 | -36.91 | -23.44 | -20.78 | Upgrade
|
| Free Cash Flow Per Share | -0.60 | -0.94 | -2.33 | -1.92 | -2.50 | Upgrade
|
| Gross Margin | 61.23% | 62.58% | 51.87% | 47.50% | 43.58% | Upgrade
|
| Operating Margin | -27.45% | -38.09% | -93.88% | -125.37% | -145.45% | Upgrade
|
| Profit Margin | -42.28% | -61.40% | -118.86% | -130.41% | -155.27% | Upgrade
|
| Free Cash Flow Margin | -21.90% | -34.54% | -99.60% | -105.42% | -112.57% | Upgrade
|
| EBITDA | -16.68 | -21.59 | -31.89 | -24.85 | -24.29 | Upgrade
|
| EBITDA Margin | -18.53% | -30.75% | -86.06% | -111.72% | -131.58% | Upgrade
|
| D&A For EBITDA | 8.04 | 5.15 | 2.9 | 3.04 | 2.56 | Upgrade
|
| EBIT | -24.72 | -26.74 | -34.79 | -27.88 | -26.85 | Upgrade
|
| EBIT Margin | -27.45% | -38.09% | -93.88% | -125.37% | -145.45% | Upgrade
|
| Revenue as Reported | - | 70.19 | 37.05 | 22.24 | 18.46 | Upgrade
|
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.